News
Latest News
Washington D.C. (April 18, 2022)—On Thursday, April 21, 2022 at 10:00 a.m. ET, Rep. Gerald E. Connolly, Chairman of the Subcommittee on Government Operations, will hold a virtual hearing to examine the operations and financial condition of the Internal Revenue Service (IRS), specifically how the agency will fare this tax season.
Washington, D.C. (April 14, 2022)—Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to ID.me CEO Blake Hall, requesting documents and information related to the company's contracts with federal, state, and local governments for use of its facial recognition technology.
Washington, D.C. (April 14, 2022)— Today, Rep. Carolyn B. Maloney, Chairwoman of the Oversight and Reform Committee, and Committee Member Rep. Ayanna Pressley released the following statements after the White House convened a meeting with all federal agencies—including all Cabinet-level agencies—to unveil its first-ever Equity Action Plans:
Washington, D.C. (April 13, 2022)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, released an interim staff report entitled, The Firm and the FDA: McKinsey & Company's Conflicts of Interest at the Heart of the Opioid Epidemic. The report presents preliminary findings from the Committee's investigation into McKinsey's consulting work during the opioid epidemic.
Washington, D.C. (April 12, 2022)— Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep.
WASHINGTON, D.C. – Today, Chairwoman Carolyn B. Maloney and U.S. Senator Tammy Baldwin (D-WI), along with Senators Maggie Hassan (D-NH) and Angus King (I-ME) and Representative Brian Fitzpatrick (R-PA), led a bicameral, bipartisan group of colleagues in sending letters to seven major manufacturers of naloxone, the opioid overdose reversal medication, urging them to apply for over the counter (OTC) status for their products to help increase access and save lives.
Washington, D.C. (April 8, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, Rep. Jamie Raskin, the Chairman of the Subcommittee on Civil Rights and Civil Liberties, and Committee Member Rep.
Washington, D.C. (April 7, 2022)—Today, Rep. Jamie Raskin, Chairman of the Subcommittee on Civil Rights and Civil Liberties, held a hearing to examine the ongoing efforts across the country to ban books from schools and public libraries.
Washington, D.C. (April 7, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, issued the following statement after the Senate unanimously confirmed Krista Boyd, Chief Counsel for Oversight and Policy for the Committee, to serve as Inspector General of the Office of Personnel Management:
Washington, D.C. (April 7, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the House Committee on Oversight and Reform, Sen. Debbie Stabenow, Chairwoman of Senate Finance Subcommittee on Health Care, and Sen. Tina Smith led colleagues—including Rep. Peter Welch and Rep. Jan Schakowsky—in introducing a package of legislation targeting business practices pharmaceutical companies use to suppress competition, maintain market monopolies, and keep drug prices high.